Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetic Nephropathy

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...

Diabetic Retinopathy

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Hyperglycemia

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Haptoglobin, hemolysis, and renal vulnerability after pulsed field ablation: The hemoglobin-binding reserve.

Heart rhythm·2026

Same author

Sotatercept as an Add-On to Background Therapy in Idiopathic Pulmonary Arterial Hypertension: Insights from a Real-World Cohort.

Pharmaceuticals (Basel, Switzerland)·2026

Same author

First Successful Implantation of the CARMAT Aeson® Total Artificial Heart as a Bridge to Heart Transplantation in Israel.

The Israel Medical Association journal : IMAJ·2026

Same author

Tailoring heart failure management in cardiac amyloidosis.

Heart failure reviews·2026

Same author

Interplay of Pulmonary Hypertension and the Effects of Panel-Reactive Antibodies on Outcomes of Heart Transplant Recipients Bridged With Left Ventricular Assist Device.

Journal of the American Heart Association·2026

Same author

Haptoglobin Phenotype and Cardiovascular Risk: The ACCORD Blood Pressure RCT.

Hypertension (Dallas, Tex. : 1979)·2025

Search research articles

Related Experiment Videos

Hypothesis--haptoglobin genotype and diabetic nephropathy.

Farid M Nakhoul¹, Rachel Miller-Lotan, Huda Awaad

¹Department of Nephrology, Rambam Health Care Campus, Haifa, Israel. f_nakhoul@rambam.health.gov.il

Nature Clinical Practice. Nephrology

|May 26, 2007

Summary

Diabetic patients with the Haptoglobin (Hp) 2-2 genotype face a higher risk of vascular complications like nephropathy and retinopathy. This genetic marker highlights the role of oxidative stress in diabetic disease progression.

Related Experiment Videos

Area of Science:

Genetics
Diabetology
Vascular Biology

Background:

Diabetic vascular complications, including nephropathy, retinopathy, and cardiovascular disease, contribute significantly to patient morbidity.
Oxidative stress is implicated in the pathogenesis of these diabetic vascular complications.
Haptoglobin (Hp) is a key protein involved in mitigating heme-driven oxidative stress, with its protective capacity varying by genotype.

Purpose of the Study:

To investigate the association between Haptoglobin (Hp) genotypes and the risk of developing vascular complications in patients with diabetes mellitus.
To determine if a specific Hp genotype is a predictive genetic marker for diabetic vascular complications.

Main Methods:

Genotyping of Haptoglobin (Hp) alleles (1 and 2) to determine Hp genotypes (Hp 1-1, Hp 2-1, Hp 2-2) in diabetic individuals.
Clinical assessment and monitoring for the development of nephropathy, retinopathy, and atherosclerotic cardiovascular disease.
Statistical analysis to correlate Hp genotype with the incidence of vascular complications.

Main Results:

Diabetic individuals possessing the Hp 2-2 genotype exhibited a significantly higher likelihood of developing nephropathy compared to those with Hp 2-1 or Hp 1-1 genotypes.
A similar increased risk for retinopathy was observed in diabetic patients with the Hp 2-2 genotype.
The Hp 2-2 genotype was also associated with an elevated risk of accelerated atherosclerotic cardiovascular disease in the diabetic population.

Conclusions:

The Haptoglobin (Hp) genotype is a significant predictive marker for vascular complications in diabetes mellitus.
The Hp 2-2 genotype is associated with an increased susceptibility to diabetic nephropathy, retinopathy, and cardiovascular disease, likely due to reduced antioxidant protection.
Targeted screening or interventions for individuals with the Hp 2-2 genotype may help mitigate the risk of severe vascular complications in diabetes.